CSL Licenses Therapeutic Antibodies From Aussie Newcomer Patrys
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Melbourne-based biotech Patrys inked a licensing deal with CSL Limited for several of Patrys' therapeutic monoclonal antibody candidates
You may also be interested in...
What Financial Crisis? Australian Biotech Enters Golden Era (Part 1 of 2)
PERTH, Australia - Australia's biotech sector has entered a golden era, with its top 20 companies now maturing, for the first time bringing products to late-stage development, and looking to commercialize
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).